All Articles
Genetic Screening and Tissue Banking: The New Standard for Parents
Overview of prenatal genetic screening and newborn tissue banking: benefits, procedures, costs, and tips for choosing a reputable provider.
What is Wharton’s Jelly? The Hidden Power of Umbilical Cord Tissue
Explains Wharton's Jelly, its mesenchymal stem cells, medical uses, and benefits of cord tissue banking for future regenerative therapies.
Pediatric to Adult: The Growing Lifespan of Cord Blood Treatments
Stored cord blood stem cells remain viable for decades, treating 80+ conditions—from pediatric cancers to emerging adult regenerative therapies.
Blood Cancer Breakthroughs: How Expanded Cord Blood is Saving Lives
FDA-approved expanded cord blood therapies raise stem cell doses, speed neutrophil recovery, reduce infections, broaden donor access, and highlight the need to bank cord blood.
Overcoming Volume Limits: The Science of Expanding Cord Blood Cells
Ex vivo cord blood expansion boosts stem cell counts to speed engraftment, lower infection risk, and enable single‑unit adult transplants.
How New FDA Approvals Make Cord Blood Transplants Viable for Adults
FDA approvals and nicotinamide expansion make cord blood transplants viable for adults, speeding recovery and lowering infection risk.
What is Stem Cell Expansion? Maximizing Your Cord Blood Investment
Explains how ex vivo stem cell expansion multiplies cord blood HSCs to enable adult transplants, faster engraftment, and broader treatment options.
Cord Blood Expansion: Why Your Baby's Stem Cells Can Now Treat Adults
Lab-expanded cord blood stem cells now enable adult transplants, shorten recovery, and make newborn banking a lasting medical resource.
The Evolution of Stem Cells: From Cord Blood to iPSC Technology
Overview of cord blood, cord tissue, placental cells, exosomes and iPSC advances, and why banking newborn cells may enable future regenerative therapies.